Qube Research & Technologies (QRT)’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-1,082,003
| Closed | -$9.87M | – | 3900 |
|
|
2025
Q2 | $9.87M | Buy |
+1,082,003
| New | +$7.96M | 0.01% | 1296 |
|
|
2024
Q4 | – | Sell |
-165,190
| Closed | -$1.19M | – | 3772 |
|
|
2024
Q3 | $1.19M | Sell |
165,190
-68,831
| -29% | -$630K | ﹤0.01% | 1967 |
|
|
2024
Q2 | $2.54M | Buy |
234,021
+127,903
| +121% | +$1.64M | ﹤0.01% | 1526 |
|
|
2024
Q1 | $1.99M | Buy |
106,118
+58,694
| +124% | +$1.35M | ﹤0.01% | 1759 |
|
|
2023
Q4 | $1.03M | Buy |
+47,424
| New | +$940K | ﹤0.01% | 1912 |
|
|
2023
Q3 | – | Sell |
-77,924
| Closed | -$3.66M | – | 4295 |
|
|
2023
Q2 | $3.66M | Buy |
+77,924
| New | +$3.88M | 0.01% | 801 |
|
|
2023
Q1 | – | Sell |
-7,953
| Closed | -$303K | – | 2963 |
|
|
2022
Q4 | $303K | Buy |
+7,953
| New | +$304K | ﹤0.01% | 1645 |
|
|
2021
Q4 | – | Sell |
-28,697
| Closed | -$1.27M | – | 2907 |
|
|
2021
Q3 | $1.27M | Buy |
28,697
+14,208
| +98% | +$652K | 0.02% | 820 |
|
|
2021
Q2 | $823K | Sell |
14,489
-49,418
| -77% | -$3.49M | 0.01% | 1029 |
|
|
2021
Q1 | $4.78M | Buy |
63,907
+48,432
| +313% | +$3.97M | 0.08% | 347 |
|
|
2020
Q4 | $1.34M | Buy |
+15,475
| New | +$1.14M | 0.02% | 771 |
|
|
2020
Q2 | – | Sell |
-26,738
| Closed | -$768K | – | 1948 |
|
|
2020
Q1 | $768K | Buy |
+26,738
| New | +$1.55M | 0.03% | 453 |
|
Other funds holding SAGE
IA
HNB